Breaks Categories: News

WednesdayOct 11, 2023 1:50 pm

NetworkNewsBreaks – Untraceable’s Flagship Conference Showcases Ever-Rising Possibilities Unlocked by Blockchain Technologies

Untraceable’s flagship event, the Blockchain Futurist Conference, recently took the spotlight at the iconic Rebel Entertainment Complex and Cabana Pool Bar. As the largest Web3 gathering in Canadian history, this year’s conference brought together global thought leaders and industry luminaries to explore the rapidly evolving technological landscape, hidden opportunities and an increasing number of innovative applications. Thousands of attendees (including developers, visionaries, startup entrepreneurs, investors, financial institutions representatives, technology enthusiasts and nearly 200 speakers) joined the conference, a cornerstone of Canada Crypto Week. IBN’s CryptoCurrencyWire served as an official newswire and a key sponsor of the event, and Jonathan Keim,…

Continue Reading

WednesdayOct 11, 2023 1:44 pm

NetworkNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Appoints Intel Capital Cofounder to Board

Renovaro BioSciences (NASDAQ: RENB), a biotechnology corporation focusing on cell, gene and immunotherapy, has announced a new member of its board of directors. Avram Miller, cofounder of Intel Capital, will join the board and will also serve in an advisory role, bringing his invaluable experience to contribute to the company's strategy and business development efforts. Miller’s impressive decades-long career includes strategic and responsible roles in both the technology and medical industries. After spending 13 years in the medical science space, he moved to high tech where, in addition to cofounding Intel Capital, he served as the company’s corporate vice president of…

Continue Reading

WednesdayOct 11, 2023 1:35 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Rapid Pace of Enrollment in Potentially Pivotal Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is reporting enrollment of 229 participants in its ongoing potentially pivotal study evaluating Berubicin for the treatment of recurrent GBM, an aggressive and incurable form of brain cancer; the company expects to ultimately enroll 243 in the study. Participants are being enrolled in 46 clinical trial sites across the United States, Italy, France, Spain and Switzerland. According to the announcement, CNS Pharmaceuticals is on track to achieve value-driving milestones before the end of the year, including…

Continue Reading

WednesdayOct 11, 2023 12:26 pm

NetworkNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) to Host Feasibility Study Conference Call and Webcast

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF) today announced that it will host a webcast and conference call at 11:00 a.m. Eastern Time on Thursday, Oct. 12, 2023, to discuss the definitive feasibility study for its Crawford Nickel Sulphide Project. Interested parties should visit https://nnw.fm/D6G2B to register for the event and access the webcast and join the call as detailed in the announcement. For those unable to participate, a web-based archive of the conference call will be available for playback at the same Audience URL used to access the live webcast. To view the full press release, visit https://nnw.fm/UkH1V About Canada…

Continue Reading

WednesdayOct 11, 2023 11:30 am

NetworkNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Receives $1.9M Funding Grant from Canadian Government ACT Program

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a Canadian-based, growth-stage company committed to providing commercially viable and sustainable, cradle-to-cradle, clean-energy solutions, will receive a funding grant of up to $1.9 million through the Research and Innovation Stream of the Agriculture Clean Technology (“ACT”) Program, delivered by Agriculture and Agri-Food Canada (“AAFC”). According to the announcement, the grant was awarded to FuelPositive’s Green NH3 Demonstration Phase Project in support of the commercialization of the FP300 Green Ammonia system. The company noted that it will use the ACT Program funding to gather key information required to continue to adapt its technology to the commercial needs…

Continue Reading

TuesdayOct 10, 2023 3:52 pm

NetworkNewsBreaks — Zevra Therapeutics Inc. (NASDAQ: ZVRA) Names New President, CEO and Director

Zevra Therapeutics (NASDAQ GS: ZVRA), a rare-disease therapeutics company, has named Neil F. McFarlane as president and CEO; McFarlane will also serve on the company’s board of directors. The new appointments are effective immediately. According to the announcement, Christal M.M. Mickle, who has been serving as interim CEO and president since June, will continue serving in her role as chief development officer. A former officer and enlisted soldier in the United States Army Reserves, McFarlane has an impressive, results-driven track record as a biopharmaceutical leader with proven ability to accelerate Zevra’s strategy of melding science, data and patient needs to…

Continue Reading

TuesdayOct 10, 2023 2:35 pm

NetworkNewsBreaks – Safety Shot Inc. (NASDAQ: SHOT) Welcomes COO Jarrett Boon to Its Board of Directors

Safety Shot (NASDAQ: SHOT) today announced that Jarrett Boon, who has served as the company’s chief operating officer since August 2023, has been appointed to Safety Shot’s board of directors. Boon is leading the launch and growth of the company’s Safety Shot functional drink business this quarter. Boon was the co-founder and CEO of GBB Drink Lab, which developed Safety Shot, the first patented beverage that helps people feel better faster by reducing blood alcohol content and boosting clarity. “In the past few months since I’ve joined the company, our outstanding team has teed up the Safety Shot drink for…

Continue Reading

TuesdayOct 10, 2023 2:30 pm

NetworkNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Announces Strategic Board Appointments of Two Finance Industry Experts

Renovaro BioSciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, today announced the appointment of Leni Boeren and Ruud Hendriks as independent directors. Both Boeren and Hendriks bring extensive, high-level experience in finance and business. Boeren has a 40-year career in the financial sector, commencing with banking roles at Paribas and Rabobank before holding several director-level positions at Amsterdam exchanges and then Euronext. Hendriks brings more than 35 years of experience in the asset management industry, having held senior roles at some of the most established financial institutions.…

Continue Reading

TuesdayOct 10, 2023 2:24 pm

NetworkNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) to Serve as Gold Sponsor of Synchrony Symposia 2023

PaxMedica (NASDAQ: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (“APT”) for the treatment of autism spectrum disorder (“ASD”) and other serious conditions, today announced its Gold Sponsorship of The BRAIN Foundation's esteemed Synchrony Symposia 2023. The globally recognized event serves as a catalyst for translational research in autism and related neurodevelopmental disorders and brings together leading scientists, clinicians, biotech and pharmaceutical companies, venture partners, and community stakeholders to foster scientific advancements that can enhance the well-being and quality of life for individuals affected by ASD. “We are honored to support The BRAIN…

Continue Reading

TuesdayOct 10, 2023 2:13 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) CEO Featured in Latest Episode of The Bell2Bell Podcast

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, is featured in the latest Bell2Bell Podcast release. During the segment, podcast host Stuart Smith discusses the company with Clene president and CEO Rob Etherington, who explains Clene’s business model and provides an overview of recent developments, which provide hope to those affected by neurodegenerative conditions. The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries. “Clene spends every waking moment working on amyotrophic lateral sclerosis (‘ALS’), a devastating neurodegenerative condition,” said Clene president…

Continue Reading